{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T20:58:36Z","timestamp":1792789116134,"version":"4.5.0"},"reference-count":150,"publisher":"MDPI AG","issue":"4","license":[{"start":{"date-parts":[[2023,2,19]],"date-time":"2023-02-19T00:00:00Z","timestamp":1676764800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"UEFISCDI, the Romanian Executive Agency for Higher Education, Research, Development and Innovation Funding","award":["PN-III-P4-PCE-2021-1140"],"award-info":[{"award-number":["PN-III-P4-PCE-2021-1140"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Diagnostics"],"abstract":"<jats:p>Non-alcoholic fatty liver disease (NAFLD), and its progressive form, non-alcoholic steatohepatitis (NASH), represent, nowadays, real challenges for the healthcare system. Liver fibrosis is the most important prognostic factor for NAFLD, and advanced fibrosis is associated with higher liver-related mortality rates. Therefore, the key issues in NAFLD are the differentiation of NASH from simple steatosis and identification of advanced hepatic fibrosis. We critically reviewed the ultrasound (US) elastography techniques for the quantitative characterization of fibrosis, steatosis, and inflammation in NAFLD and NASH, with a specific focus on how to differentiate advanced fibrosis in adult patients. Vibration-controlled transient elastography (VCTE) is still the most utilized and validated elastography method for liver fibrosis assessment. The recently developed point shear wave elastography (pSWE) and two-dimensional shear wave elastography (2D-SWE) techniques that use multiparametric approaches could bring essential improvements to diagnosis and risk stratification.<\/jats:p>","DOI":"10.3390\/diagnostics13040788","type":"journal-article","created":{"date-parts":[[2023,2,20]],"date-time":"2023-02-20T05:57:52Z","timestamp":1676872672000},"page":"788","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":25,"title":["How to Identify Advanced Fibrosis in Adult Patients with Non-Alcoholic Fatty Liver Disease (NAFLD) and Non-Alcoholic Steatohepatitis (NASH) Using Ultrasound Elastography\u2014A Review of the Literature and Proposed Multistep Approach"],"prefix":"10.3390","volume":"13","author":[{"given":"Madalina-Gabriela","family":"Taru","sequence":"first","affiliation":[{"name":"Hepatology Department, Regional Institute of Gastroenterology and Hepatology \u201cOctavian Fodor\u201d, 400162 Cluj-Napoca, Romania"},{"name":"Faculty of Medicine, \u201cIuliu Hatieganu\u201d University of Medicine and Pharmacy, 400012 Cluj-Napoca, Romania"},{"name":"Department of Medical and Surgical Sciences, University of Bologna, 40126 Bologna, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5322-3724","authenticated-orcid":false,"given":"Lidia","family":"Neamti","sequence":"additional","affiliation":[{"name":"Hepatology Department, Regional Institute of Gastroenterology and Hepatology \u201cOctavian Fodor\u201d, 400162 Cluj-Napoca, Romania"},{"name":"Faculty of Medicine, \u201cIuliu Hatieganu\u201d University of Medicine and Pharmacy, 400012 Cluj-Napoca, Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vlad","family":"Taru","sequence":"additional","affiliation":[{"name":"Hepatology Department, Regional Institute of Gastroenterology and Hepatology \u201cOctavian Fodor\u201d, 400162 Cluj-Napoca, Romania"},{"name":"Faculty of Medicine, \u201cIuliu Hatieganu\u201d University of Medicine and Pharmacy, 400012 Cluj-Napoca, Romania"},{"name":"Division of Gastroenterology and Hepatology, Department of Medicine III, Medical University of Vienna, 1090 Vienna, Austria"},{"name":"Christian Doppler Lab for Portal Hypertension and Liver Fibrosis, Medical University of Vienna, 1090 Vienna, Austria"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lucia Maria","family":"Procopciuc","sequence":"additional","affiliation":[{"name":"Faculty of Medicine, \u201cIuliu Hatieganu\u201d University of Medicine and Pharmacy, 400012 Cluj-Napoca, Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bogdan","family":"Procopet","sequence":"additional","affiliation":[{"name":"Hepatology Department, Regional Institute of Gastroenterology and Hepatology \u201cOctavian Fodor\u201d, 400162 Cluj-Napoca, Romania"},{"name":"Faculty of Medicine, \u201cIuliu Hatieganu\u201d University of Medicine and Pharmacy, 400012 Cluj-Napoca, Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7918-1956","authenticated-orcid":false,"given":"Monica","family":"Lupsor-Platon","sequence":"additional","affiliation":[{"name":"Faculty of Medicine, \u201cIuliu Hatieganu\u201d University of Medicine and Pharmacy, 400012 Cluj-Napoca, Romania"},{"name":"Medical Imaging Department, Regional Institute of Gastroenterology and Hepatology \u201cOctavian Fodor\u201d, 400162 Cluj-Napoca, Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2023,2,19]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1016\/S2468-1253(22)00165-0","article-title":"The prevalence and incidence of NAFLD worldwide: A systematic review and meta-analysis","volume":"7","author":"Riazi","year":"2022","journal-title":"Lancet Gastroenterol. Hepatol."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1002\/hep.28431","article-title":"Global epidemiology of nonalcoholic fatty liver disease-Meta-analytic assessment of prevalence, incidence, and outcomes","volume":"64","author":"Younossi","year":"2016","journal-title":"Hepatology"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"2809","DOI":"10.1016\/j.cgh.2021.12.002","article-title":"2019 Global NAFLD Prevalence: A Systematic Review and Meta-analysis","volume":"20","author":"Le","year":"2021","journal-title":"Clin. Gastroenterol. Hepatol."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1016\/j.jhep.2018.05.011","article-title":"Burden of liver disease in Europe: Epidemiology and analysis of risk factors to identify prevention policies","volume":"69","author":"Pimpin","year":"2018","journal-title":"J. Hepatol."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"1615","DOI":"10.1056\/NEJMe2110989","article-title":"Nonalcoholic Steatohepatitis\u2014Opportunities and Challenges","volume":"385","year":"2021","journal-title":"N. Engl. J. Med."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"2537","DOI":"10.1016\/j.cell.2021.04.015","article-title":"Mechanisms and disease consequences of nonalcoholic fatty liver disease","volume":"184","author":"Loomba","year":"2021","journal-title":"Cell"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"1237","DOI":"10.1016\/j.jhep.2022.07.004","article-title":"Clinical course of non-alcoholic fatty liver disease and the implications for clinical trial design","volume":"77","author":"Allen","year":"2022","journal-title":"J. Hepatol."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"2063","DOI":"10.1056\/NEJMra1503519","article-title":"Cause, Pathogenesis, and Treatment of Nonalcoholic Steatohepatitis","volume":"377","author":"Diehl","year":"2017","journal-title":"N. Engl. J. Med."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.1002\/hep.20701","article-title":"Design and validation of a histological scoring system for nonalcoholic fatty liver disease","volume":"41","author":"Kleiner","year":"2005","journal-title":"Hepatology"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"1307","DOI":"10.3748\/wjg.v25.i11.1307","article-title":"Noninvasive evaluation of nonalcoholic fatty liver disease: Current evidence and practice","volume":"25","author":"Zhou","year":"2019","journal-title":"World J. Gastroenterol."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"1898","DOI":"10.1053\/j.gastro.2005.03.084","article-title":"Sampling Variability of Liver Biopsy in Nonalcoholic Fatty Liver Disease","volume":"128","author":"Ratziu","year":"2005","journal-title":"Gastroenterology"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"1999","DOI":"10.1053\/j.gastro.2019.11.312","article-title":"MAFLD: A Consensus-Driven Proposed Nomenclature for Metabolic Associated Fatty Liver Disease","volume":"158","author":"Eslam","year":"2020","journal-title":"Gastroenterology"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"1202","DOI":"10.1053\/jhep.2003.50193","article-title":"Nonalcoholic steatohepatitis: Summary of an AASLD Single Topic Conference","volume":"37","author":"Caldwell","year":"2003","journal-title":"Hepatology"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"2082","DOI":"10.1111\/liv.14548","article-title":"Comparison of MAFLD and NAFLD diagnostic criteria in real world","volume":"40","author":"Lin","year":"2020","journal-title":"Liver Int."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"1423","DOI":"10.1002\/hep.32499","article-title":"Are there outcome differences between NAFLD and metabolic-associated fatty liver disease?","volume":"76","author":"Younossi","year":"2022","journal-title":"Hepatology"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"1194","DOI":"10.1002\/hep.31420","article-title":"From NAFLD to MAFLD: Implications of a Premature Change in Terminology","volume":"73","author":"Younossi","year":"2020","journal-title":"Hepatology"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"1557","DOI":"10.1002\/hep.29085","article-title":"Increased risk of mortality by fibrosis stage in nonalcoholic fatty liver disease: Systematic review and meta-analysis","volume":"65","author":"Dulai","year":"2017","journal-title":"Hepatology"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"1611","DOI":"10.1053\/j.gastro.2020.01.043","article-title":"Association Between Fibrosis Stage and Outcomes of Patients With Nonalcoholic Fatty Liver Disease: A Systematic Review and Meta-Analysis","volume":"158","author":"Taylor","year":"2020","journal-title":"Gastroenterology"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"1559","DOI":"10.1056\/NEJMoa2029349","article-title":"Prospective Study of Outcomes in Adults with Nonalcoholic Fatty Liver Disease","volume":"385","author":"Sanyal","year":"2021","journal-title":"N. Engl. J. Med."},{"key":"ref_20","doi-asserted-by":"crossref","unstructured":"Ng, C.H., Lim, W.H., Hui Lim, G.E., Hao Tan, D.J., Syn, N., Muthiah, M.D., Huang, D.Q., and Loomba, R. Mortality Outcomes by Fibrosis Stage in Nonalcoholic Fatty Liver Disease: A Systematic Review and Meta-analysis. Clin. Gastroenterol. Hepatol., 2022.","DOI":"10.1016\/j.cgh.2022.04.014"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1038\/s41575-021-00523-4","article-title":"Advancing the global public health agenda for NAFLD: A consensus statement","volume":"19","author":"Lazarus","year":"2021","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"533","DOI":"10.4254\/wjh.v9.i11.533","article-title":"Hepatocellular carcinoma in non-alcoholic steatohepatitis: Current knowledge and implications for management","volume":"9","author":"Cholankeril","year":"2017","journal-title":"World J. Hepatol."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1016\/j.cld.2015.01.012","article-title":"Nonalcoholic Fatty Liver Disease, Diabetes, Obesity, and Hepatocellular Carcinoma","volume":"19","author":"Noureddin","year":"2015","journal-title":"Clin. Liver Dis."},{"key":"ref_24","doi-asserted-by":"crossref","unstructured":"Plaz Torres, M.C., Bodini, G., Furnari, M., Marabotto, E., Zentilin, P., Strazzabosco, M., and Giannini, E.G. (2020). Surveillance for Hepatocellular Carcinoma in Patients with Non-Alcoholic Fatty Liver Disease: Universal or Selective?. Cancers, 12.","DOI":"10.3390\/cancers12061422"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1016\/j.jhep.2021.04.044","article-title":"Diagnostic accuracy of elastography and magnetic resonance imaging in patients with NAFLD: A systematic review and meta-analysis","volume":"75","author":"Selvaraj","year":"2021","journal-title":"J. Hepatol."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"e16","DOI":"10.1055\/s-0043-103952","article-title":"EFSUMB Guidelines and Recommendations on the Clinical Use of Liver Ultrasound Elastography, Update 2017 (Long Version)","volume":"38","author":"Dietrich","year":"2017","journal-title":"Ultraschall Med."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"2419","DOI":"10.1016\/j.ultrasmedbio.2018.07.008","article-title":"Liver Ultrasound Elastography: An Update to the World Federation for Ultrasound in Medicine and Biology Guidelines and Recommendations","volume":"44","author":"Ferraioli","year":"2018","journal-title":"Ultrasound Med. Biol."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1148\/radiol.2020192437","article-title":"Update to the Society of Radiologists in Ultrasound Liver Elastography Consensus Statement","volume":"296","author":"Barr","year":"2020","journal-title":"Radiology"},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"7236","DOI":"10.3748\/wjg.v22.i32.7236","article-title":"Transient elastography (FibroScan\u00ae) with controlled attenuation parameter in the assessment of liver steatosis and fibrosis in patients with nonalcoholic fatty liver disease\u2014Where do we stand?","volume":"22","author":"Mikolasevic","year":"2016","journal-title":"World J. Gastroenterol."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"1705","DOI":"10.1016\/j.ultrasmedbio.2003.07.001","article-title":"Transient elastography: A new noninvasive method for assessment of hepatic fibrosis","volume":"29","author":"Sandrin","year":"2003","journal-title":"Ultrasound Med. Biol."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"e11816","DOI":"10.1097\/MD.0000000000011816","article-title":"Feasibility and Efficacy of Transient Elastography using the XL probe to diagnose liver fibrosis and cirrhosis: A meta-analysis","volume":"97","author":"Xia","year":"2018","journal-title":"Medicine"},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"1022","DOI":"10.1080\/00365521.2019.1644367","article-title":"Transient elastography: Should XL probe be used in all overweight patients?","volume":"54","author":"Arieira","year":"2019","journal-title":"Scand. J. Gastroenterol."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"1303","DOI":"10.7150\/thno.18650","article-title":"Ultrasound Elastography: Review of Techniques and Clinical Applications","volume":"7","author":"Sigrist","year":"2017","journal-title":"Theranostics"},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"1987","DOI":"10.1148\/rg.2016160042","article-title":"Elastography in Chronic Liver Disease: Modalities, Techniques, Limitations, and Future Directions","volume":"36","author":"Babu","year":"2016","journal-title":"Radiographics"},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"4574","DOI":"10.2174\/1381612825666190117102111","article-title":"Diagnosis of Non-alcoholic Fatty Liver Disease (NAFLD): Current Concepts","volume":"24","author":"Papatheodoridi","year":"2019","journal-title":"Curr. Pharm. Des."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1016\/j.jhep.2006.11.010","article-title":"Features associated with success rate and performance of fibroscan measurements for the diagnosis of cirrhosis in HCV patients: A prospective study of 935 patients","volume":"46","author":"Kettaneh","year":"2007","journal-title":"J. Hepatol."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1097\/MEG.0b013e3282f51992","article-title":"Learning curve and interobserver reproducibility evaluation of liver stiffness measurement by transient elastography","volume":"20","author":"Boursier","year":"2008","journal-title":"Eur. J. Gastroenterol. Hepatol."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1038\/ajg.2016.49","article-title":"The Performance of Vibration Controlled Transient Elastography in a US Cohort of Patients With Nonalcoholic Fatty Liver Disease","volume":"111","author":"Tapper","year":"2016","journal-title":"Am. J. Gastroenterol."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1111\/j.1440-1746.2010.06510.x","article-title":"Factors associated with unreliable liver stiffness measurement and its failure with transient elastography in the Chinese population","volume":"26","author":"Wong","year":"2010","journal-title":"J. Gastroenterol. Hepatol."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1002\/hep.24624","article-title":"Feasibility and diagnostic performance of the FibroScan XL probe for liver stiffness measurement in overweight and obese patients","volume":"55","author":"Myers","year":"2011","journal-title":"Hepatology"},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1016\/j.jhep.2011.10.007","article-title":"Discordance in fibrosis staging between liver biopsy and transient elastography using the FibroScan XL probe","volume":"56","author":"Myers","year":"2012","journal-title":"J. Hepatol."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1111\/j.1365-2893.2006.00811.x","article-title":"Transient elastography: A new surrogate marker of liver fibrosis influenced by major changes of transaminases","volume":"14","author":"Coco","year":"2007","journal-title":"J. Viral Hepat."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1002\/hep.22056","article-title":"Transient elastography is unreliable for detection of cirrhosis in patients with acute liver damage","volume":"47","author":"Sagir","year":"2007","journal-title":"Hepatology"},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1002\/hep.22007","article-title":"Acute viral hepatitis increases liver stiffness values measured by transient elastography","volume":"47","author":"Arena","year":"2007","journal-title":"Hepatology"},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"1718","DOI":"10.1002\/hep.22577","article-title":"Extrahepatic cholestasis increases liver stiffness (FibroScan) irrespective of fibrosis","volume":"48","author":"Millonig","year":"2008","journal-title":"Hepatology"},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1016\/j.jhep.2009.11.018","article-title":"Liver stiffness is directly influenced by central venous pressure","volume":"52","author":"Millonig","year":"2009","journal-title":"J. Hepatol."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1002\/hep.27844","article-title":"The severity of steatosis influences liver stiffness measurement in patients with nonalcoholic fatty liver disease","volume":"62","author":"Petta","year":"2015","journal-title":"Hepatology"},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"35","DOI":"10.15403\/jgld.2014.1121.mlp","article-title":"Diagnostic Accuracy of Controlled Attenuation Parameter Measured by Transient Elastography for the Non-invasive Assessment of Liver Steatosis: A Prospective Study","volume":"24","author":"Feier","year":"2015","journal-title":"J. Gastrointest. Liver Dis."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.jhep.2010.06.022","article-title":"Reliability of transient elastography for the detection of fibrosis in Non-Alcoholic Fatty Liver Disease and chronic viral hepatitis","volume":"54","author":"Gaia","year":"2011","journal-title":"J. Hepatol."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"2057","DOI":"10.1136\/gutjnl-2018-317334","article-title":"Unified interpretation of liver stiffness measurement by M and XL probes in non-alcoholic fatty liver disease","volume":"68","author":"Wong","year":"2019","journal-title":"Gut"},{"key":"ref_51","first-page":"959","article-title":"Baveno VII\u2014Renewing consensus in portal hypertension","volume":"76","author":"Bosch","year":"2021","journal-title":"J. Hepatol."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"100596","DOI":"10.1016\/j.jhepr.2022.100596","article-title":"Real-world evidence on non-invasive tests and associated cut-offs used to assess fibrosis in routine clinical practice","volume":"5","author":"Lazarus","year":"2022","journal-title":"JHEP Rep."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.clinre.2011.08.001","article-title":"The controlled attenuation parameter (CAP): A novel tool for the non-invasive evaluation of steatosis using Fibroscan\u00ae","volume":"36","author":"Sasso","year":"2012","journal-title":"Clin. Res. Hepatol. Gastroenterol."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"1022","DOI":"10.1016\/j.jhep.2016.12.022","article-title":"Individual patient data meta-analysis of controlled attenuation parameter (CAP) technology for assessing steatosis","volume":"66","author":"Karlas","year":"2017","journal-title":"J. Hepatol."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1055\/s-0029-1245360","article-title":"Acoustic Radiation Force Impulse Elastography as Compared to Transient Elastography and Liver Biopsy in Patients with Chronic Hepatopathies","volume":"32","author":"Sporea","year":"2010","journal-title":"Ultraschall Med."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1097\/RUQ.0000000000000209","article-title":"Elastography Assessment of Liver Fibrosis: Society of Radiologists in Ultrasound Consensus Conference Statement","volume":"32","author":"Barr","year":"2016","journal-title":"Ultrasound Q."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1016\/j.ultrasmedbio.2013.10.021","article-title":"Influence of Measurement Depth on the Stiffness Assessment of Healthy Liver with Real-Time Shear Wave Elastography","volume":"40","author":"Wang","year":"2014","journal-title":"Ultrasound Med. Biol."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"1068","DOI":"10.1016\/j.jhep.2014.12.007","article-title":"Real-time shear-wave elastography: Applicability, reliability and accuracy for clinically significant portal hypertension","volume":"62","author":"Procopet","year":"2015","journal-title":"J. Hepatol."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"2578","DOI":"10.1016\/j.ultrasmedbio.2018.07.031","article-title":"Point Shear Wave Elastography for Non-invasive Assessment of Liver Fibrosis in Patients with Viral Hepatitis","volume":"44","author":"Bucsics","year":"2018","journal-title":"Ultrasound Med. Biol."},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1148\/radiol.2018172104","article-title":"Reducing the Number of Measurements in Liver Point Shear-Wave Elastography: Factors that Influence the Number and Reliability of Measurements in Assessment of Liver Fibrosis in Clinical Practice","volume":"287","author":"Fang","year":"2018","journal-title":"Radiology"},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"1056","DOI":"10.1016\/j.dld.2018.03.033","article-title":"Adherence to quality criteria improves concordance between transient elastography and ElastPQ for liver stiffness assessment\u2014A multicenter retrospective study","volume":"50","author":"Ferraioli","year":"2018","journal-title":"Dig. Liver Dis."},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1016\/j.ultrasmedbio.2012.11.013","article-title":"The Influence of Food Intake on Liver Stiffness Values Assessed by Acoustic Radiation Force Impulse Elastography\u2014Preliminary Results","volume":"39","author":"Popescu","year":"2013","journal-title":"Ultrasound Med. Biol."},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1016\/j.dld.2013.02.008","article-title":"The influence of aminotransferase levels on liver stiffness assessed by Acoustic Radiation Force Impulse Elastography: A retrospective multicentre study","volume":"45","author":"Bota","year":"2013","journal-title":"Dig. Liver Dis."},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"328","DOI":"10.2174\/157340511798038657","article-title":"Acoustic Radiation Force Impulse (ARFI) Imaging: A Review","volume":"7","author":"Nightingale","year":"2011","journal-title":"Curr. Med. Imaging Rev."},{"key":"ref_65","first-page":"303","article-title":"Performance of a new elastographic method (ARFI technology) compared to unidimensional transient elastography in the noninvasive assessment of chronic hepatitis C. Preliminary results","volume":"18","author":"Lupsor","year":"2009","journal-title":"J. Gastrointest. Liver Dis."},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1148\/radiol.2523081928","article-title":"Liver fibrosis in viral hepatitis: Noninvasive assessment with acoustic radiation force impulse im-aging versus transient elastography","volume":"252","author":"Wunder","year":"2009","journal-title":"Radiology"},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1016\/j.jhep.2010.12.019","article-title":"Noninvasive evaluation of hepatic fibrosis using acoustic radiation force-based shear stiffness in patients with nonalcoholic fatty liver disease","volume":"55","author":"Palmeri","year":"2011","journal-title":"J. Hepatol."},{"key":"ref_68","doi-asserted-by":"crossref","unstructured":"Lin, Y., Li, H., Jin, C., Wang, H., and Jiang, B. (2020). The diagnostic accuracy of liver fibrosis in non-viral liver diseases using acoustic radiation force impulse elastography: A systematic review and meta-analysis. PLoS ONE, 15.","DOI":"10.1371\/journal.pone.0227358"},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.jceh.2020.06.005","article-title":"Comparison of Elastography Point Quantification with Transient Elastography in Patients with Chronic Viral Hepatitis and Nonalcoholic Fatty Liver Disease: A Pilot Study","volume":"11","author":"Kapur","year":"2020","journal-title":"J. Clin. Exp. Hepatol."},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1007\/s11547-022-01475-8","article-title":"Comparison of point shear wave elastography and transient elastography in the evaluation of patients with NAFLD","volume":"127","author":"Argalia","year":"2022","journal-title":"Radiol. Med."},{"key":"ref_71","doi-asserted-by":"crossref","unstructured":"Bauer, D.J., Matic, V., Mare, R., Maiocchi, L., Chromy, D., M\u00fcllner-Bucsics, T., Mandorfer, M., Mustapic, S., Sporea, I., and Ferraioli, G. (2022). Point Shear Wave Elastography by ElastPQ for Fibrosis Screening in Patients with NAFLD: A Prospective, Multicenter Comparison to Vibration-Controlled Elastography. Ultraschall Med.","DOI":"10.1055\/a-1724-7289"},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1111\/jgh.14782","article-title":"Comparing point shear wave elastography (ElastPQ) and transient elastography for diagnosis of fibrosis stage in non-alcoholic fatty liver disease","volume":"35","author":"Leong","year":"2019","journal-title":"J. Gastroenterol. Hepatol."},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/j.ultrasmedbio.2008.08.018","article-title":"Quantitative Viscoelasticity Mapping of Human Liver Using Supersonic Shear Imaging: Preliminary In Vivo Feasability Study","volume":"35","author":"Muller","year":"2009","journal-title":"Ultrasound Med. Biol."},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"3102","DOI":"10.1016\/j.ejrad.2012.05.030","article-title":"Reproducibility of real-time shear wave elastography in the evaluation of liver elasticity","volume":"81","author":"Ferraioli","year":"2012","journal-title":"Eur. J. Radiol."},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1016\/j.jhep.2014.04.044","article-title":"Non-invasive assessment of liver fibrosis with impulse elastography: Comparison of Supersonic Shear Imaging with ARFI and FibroScan\u00ae","volume":"61","author":"Cassinotto","year":"2014","journal-title":"J. Hepatol."},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"2258","DOI":"10.1016\/j.ultrasmedbio.2022.06.018","article-title":"Inter-platform Variability of Liver Elastography: Pairwise Comparisons of Four Devices","volume":"48","author":"Cassinotto","year":"2022","journal-title":"Ultrasound Med. Biol."},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"1817","DOI":"10.1002\/hep.28394","article-title":"Liver stiffness in nonalcoholic fatty liver disease: A comparison of supersonic shear imaging, FibroScan, and ARFI with liver biopsy","volume":"63","author":"Cassinotto","year":"2016","journal-title":"Hepatology"},{"key":"ref_78","doi-asserted-by":"crossref","unstructured":"Lee, M.S., Bae, J.M., Joo, S.K., Woo, H., Lee, D.H., Jung, Y.J., Kim, B.G., Lee, K.L., and Kim, W. (2017). Prospective comparison among transient elastography, supersonic shear imaging, and ARFI imaging for predicting fibrosis in nonalcoholic fatty liver disease. PLoS ONE, 12.","DOI":"10.1371\/journal.pone.0188321"},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1007\/s10396-017-0840-3","article-title":"Liver fibrosis: Noninvasive assessment using supersonic shear imaging and FIB4 index in patients with non-alcoholic fatty liver disease","volume":"45","author":"Takeuchi","year":"2017","journal-title":"J. Med. Ultrason."},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1002\/hep.29179","article-title":"Assessment of biopsy-proven liver fibrosis by two-dimensional shear wave elastography: An individual patient data-based meta-analysis","volume":"67","author":"Herrmann","year":"2018","journal-title":"Hepatology"},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"972","DOI":"10.1016\/j.ultrasmedbio.2019.12.020","article-title":"Diagnostic Accuracy of Shear Wave Elastography as a Non-invasive Biomarker of High-Risk Non-alcoholic Steatohepatitis in Patients with Non-alcoholic Fatty Liver Disease","volume":"46","author":"Ozturk","year":"2020","journal-title":"Ultrasound Med. Biol."},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"17562848211050436","DOI":"10.1177\/17562848211050436","article-title":"Diagnostic accuracy of two-dimensional shear wave elastography and transient elastography in nonalcoholic fatty liver disease","volume":"14","author":"Sharpton","year":"2021","journal-title":"Ther. Adv. Gastroenterol."},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"1800","DOI":"10.21037\/qims-21-700","article-title":"Diagnosis of steatohepatitis and fibrosis in biopsy-proven nonalcoholic fatty liver diseases: Including two-dimension real-time shear wave elastography and noninvasive fibrotic biomarker scores","volume":"12","author":"Zhou","year":"2022","journal-title":"Quant. Imaging Med. Surg."},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"2196","DOI":"10.1002\/hep.31655","article-title":"Transient Versus Two-Dimensional Shear-Wave Elastography in a Multistep Strategy to Detect Advanced Fibrosis in NAFLD","volume":"73","author":"Cassinotto","year":"2020","journal-title":"Hepatology"},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1016\/j.cgh.2020.05.034","article-title":"Accuracy of Two-Dimensional Shear Wave Elastography and Attenuation Imaging for Evaluation of Patients With Nonalcoholic Steatohepatitis","volume":"19","author":"Lee","year":"2020","journal-title":"Clin. Gastroenterol. Hepatol."},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1148\/radiol.2020192665","article-title":"The Role of Multiparametric US of the Liver for the Evaluation of Nonalcoholic Steatohepatitis","volume":"296","author":"Sugimoto","year":"2020","journal-title":"Radiology"},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1148\/radiol.220220","article-title":"Two-dimensional Shear-Wave Elastography and US Attenuation Imaging for Nonalcoholic Steatohepatitis Diagnosis: A Cross-sectional, Multicenter Study","volume":"305","author":"Jang","year":"2022","journal-title":"Radiology"},{"key":"ref_88","doi-asserted-by":"crossref","unstructured":"Kuroda, H., Fujiwara, Y., Abe, T., Nagasawa, T., Oguri, T., Noguchi, S., Kamiyama, N., and Takikawa, Y. (2021). Two-dimensional shear wave elastography and ultrasound-guided attenuation parameter for progressive non-alcoholic steatohepatitis. PLoS ONE, 16.","DOI":"10.1371\/journal.pone.0249493"},{"key":"ref_89","doi-asserted-by":"crossref","first-page":"2457","DOI":"10.1007\/s00330-021-08369-9","article-title":"Comparative diagnostic performance of ultrasound shear wave elastography and magnetic resonance elastography for classifying fibrosis stage in adults with biopsy-proven nonalcoholic fatty liver disease","volume":"32","author":"Zhang","year":"2022","journal-title":"Eur. Radiol."},{"key":"ref_90","doi-asserted-by":"crossref","first-page":"1271","DOI":"10.1002\/hep.25756","article-title":"Real-time tissue elastography for evaluation of hepatic fibrosis and portal hypertension in nonalcoholic fatty liver diseases","volume":"56","author":"Ochi","year":"2012","journal-title":"Hepatology"},{"key":"ref_91","doi-asserted-by":"crossref","first-page":"1486","DOI":"10.1002\/hep.29302","article-title":"Comparison of laboratory tests, ultrasound, or magnetic resonance elastography to detect fibrosis in patients with nonalcoholic fatty liver disease: A meta-analysis","volume":"66","author":"Xiao","year":"2017","journal-title":"Hepatology"},{"key":"ref_92","doi-asserted-by":"crossref","first-page":"2971","DOI":"10.1016\/j.cgh.2020.04.034","article-title":"Agreement Between 2-Dimensional Shear Wave and Transient Elastography Values for Diagnosis of Advanced Chronic Liver Disease","volume":"18","author":"Cassinotto","year":"2020","journal-title":"Clin. Gastroenterol. Hepatol."},{"key":"ref_93","doi-asserted-by":"crossref","first-page":"e00081","DOI":"10.14309\/ctg.0000000000000081","article-title":"Detection of Liver Steatosis With a Novel Ultrasound-Based Technique: A pilot study using MRI-derived proton density fat fraction as the gold standard","volume":"10","author":"Ferraioli","year":"2019","journal-title":"Clin. Transl. Gastroenterol."},{"key":"ref_94","doi-asserted-by":"crossref","first-page":"1407","DOI":"10.1016\/j.ultrasmedbio.2019.02.008","article-title":"Prospective Evaluation of Hepatic Steatosis Using Ultrasound Attenuation Imaging in Patients with Chronic Liver Disease with Magnetic Resonance Imaging Proton Density Fat Fraction as the Reference Standard","volume":"45","author":"Jeon","year":"2019","journal-title":"Ultrasound Med. Biol."},{"key":"ref_95","doi-asserted-by":"crossref","first-page":"265","DOI":"10.11152\/mu-2495","article-title":"Quantification of Steatosis and Fibrosis using a new system implemented in an ultrasound machine","volume":"22","author":"Sporea","year":"2020","journal-title":"Med. Ultrason."},{"key":"ref_96","doi-asserted-by":"crossref","first-page":"6499","DOI":"10.1007\/s00330-019-06272-y","article-title":"Assessment of hepatic steatosis by using attenuation imaging: A quantitative, easy-to-perform ultrasound technique","volume":"29","author":"Bae","year":"2019","journal-title":"Eur. Radiol."},{"key":"ref_97","doi-asserted-by":"crossref","first-page":"2679","DOI":"10.1016\/j.ultrasmedbio.2019.05.033","article-title":"Usefulness of Attenuation Imaging with an Ultrasound Scanner for the Evaluation of Hepatic Steatosis","volume":"45","author":"Tada","year":"2019","journal-title":"Ultrasound Med. Biol."},{"key":"ref_98","doi-asserted-by":"crossref","first-page":"2293","DOI":"10.1007\/s00330-019-06480-6","article-title":"Quantification of hepatic steatosis with ultrasound: Promising role of attenuation imaging coefficient in a biopsy-proven cohort","volume":"30","author":"Ronot","year":"2020","journal-title":"Eur. Radiol."},{"key":"ref_99","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1007\/s10396-021-01123-0","article-title":"Diagnostic accuracy of ultrasound-guided attenuation parameter as a noninvasive test for steatosis in non-alcoholic fatty liver disease","volume":"48","author":"Kuroda","year":"2021","journal-title":"J. Med. Ultrason."},{"key":"ref_100","doi-asserted-by":"crossref","first-page":"2223","DOI":"10.1016\/j.ultrasmedbio.2018.06.017","article-title":"The B-Mode Image-Guided Ultrasound Attenuation Parameter Accurately Detects Hepatic Steatosis in Chronic Liver Disease","volume":"44","author":"Fujiwara","year":"2018","journal-title":"Ultrasound Med. Biol."},{"key":"ref_101","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1002\/jgh3.12615","article-title":"The ultrasound-guided attenuation parameter is useful in quantification of hepatic steatosis in non-alcoholic fatty liver disease","volume":"5","author":"Ogino","year":"2021","journal-title":"JGH Open"},{"key":"ref_102","doi-asserted-by":"crossref","first-page":"3","DOI":"10.14366\/usg.19031","article-title":"Clinical utilization of shear wave dispersion imaging in diffuse liver disease","volume":"39","author":"Sugimoto","year":"2020","journal-title":"Ultrasonography"},{"key":"ref_103","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1148\/radiol.212609","article-title":"US Shear-Wave Elastography Dispersion for Characterization of Chronic Liver Disease","volume":"305","author":"Zhang","year":"2022","journal-title":"Radiology"},{"key":"ref_104","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1148\/radiol.2019190064","article-title":"Shear-Wave Dispersion Slope from US Shear-Wave Elastography: Detection of Allograft Damage after Liver Transplantation","volume":"293","author":"Lee","year":"2019","journal-title":"Radiology"},{"key":"ref_105","doi-asserted-by":"crossref","first-page":"5044","DOI":"10.21037\/qims-22-374","article-title":"Efficacy of shear wave dispersion imaging for viscoelastic assessment of the liver in acute graft-versus-host disease rats","volume":"12","author":"Xiong","year":"2022","journal-title":"Quant. Imaging Med. Surg."},{"key":"ref_106","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/j.jhep.2022.10.034","article-title":"Enhanced diagnosis of advanced fibrosis and cirrhosis in individuals with NAFLD using FibroScan-based Agile scores","volume":"78","author":"Sanyal","year":"2022","journal-title":"J. Hepatol."},{"key":"ref_107","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1016\/S2468-1253(19)30383-8","article-title":"FibroScan-AST (FAST) score for the non-invasive identification of patients with non-alcoholic steatohepatitis with significant activity and fibrosis: A prospective derivation and global validation study","volume":"5","author":"Newsome","year":"2020","journal-title":"Lancet Gastroenterol. Hepatol."},{"key":"ref_108","first-page":"357","article-title":"Screening for Nonalcoholic Fatty Liver Disease in the Primary Care Clinic","volume":"15","author":"Pandyarajan","year":"2019","journal-title":"Gastroenterol. Hepatol."},{"key":"ref_109","doi-asserted-by":"crossref","unstructured":"Woreta, T.A., Van Natta, M.L., Lazo, M., Krishnan, A., Neuschwander-Tetri, B.A., Loomba, R., Mae Diehl, A., Abdelmalek, M.F., Chalasani, N., and Gawrieh, S. (2022). Validation of the accuracy of the FAST\u2122 score for detecting patients with at-risk nonalcoholic steatohepatitis (NASH) in a North American cohort and comparison to other non-invasive algorithms. PLoS ONE, 17.","DOI":"10.1371\/journal.pone.0266859"},{"key":"ref_110","doi-asserted-by":"crossref","first-page":"869190","DOI":"10.3389\/fmed.2022.869190","article-title":"Comparison of FibroScan-Aspartate Aminotransferase (FAST) Score and Other Non-invasive Surrogates in Predicting High-Risk Non-alcoholic Steatohepatitis Criteria","volume":"9","author":"Lee","year":"2022","journal-title":"Front. Med."},{"key":"ref_111","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1016\/j.jceh.2021.06.008","article-title":"FibroScan-AST (FAST) Score for Nonalcoholic Steatohepatitis\u2014Validation in an Indian Cohort","volume":"12","author":"De","year":"2021","journal-title":"J. Clin. Exp. Hepatol."},{"key":"ref_112","doi-asserted-by":"crossref","first-page":"5272","DOI":"10.1007\/s10620-021-07363-x","article-title":"Validation and Performance of FibroScan\u00ae-AST (FAST) Score on a Brazilian Population with Nonalcoholic Fatty Liver Disease","volume":"67","author":"Cardoso","year":"2022","journal-title":"Dig. Dis. Sci."},{"key":"ref_113","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1148\/radiol.2021210046","article-title":"Multiparametric US for Identifying Patients with High-Risk NASH: A Derivation and Validation Study","volume":"301","author":"Sugimoto","year":"2021","journal-title":"Radiology"},{"key":"ref_114","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1053\/j.gastro.2007.05.024","article-title":"Hepatic Venous Pressure Gradient Predicts Clinical Decompensation in Patients With Compensated Cirrhosis","volume":"133","author":"Ripoll","year":"2007","journal-title":"Gastroenterology"},{"key":"ref_115","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1016\/j.jhep.2015.05.022","article-title":"Expanding consensus in portal hypertension: Report of the Baveno VI Consensus Workshop: Stratifying risk and individualizing care for portal hypertension","volume":"63","author":"Baveno","year":"2015","journal-title":"J. Hepatol."},{"key":"ref_116","doi-asserted-by":"crossref","first-page":"1597","DOI":"10.1016\/S0140-6736(18)31875-0","article-title":"\u03b2 blockers to prevent decompensation of cirrhosis in patients with clinically significant portal hypertension (PREDESCI): A randomised, double-blind, placebo-controlled, multicentre trial","volume":"393","author":"Villanueva","year":"2019","journal-title":"Lancet"},{"key":"ref_117","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1053\/j.gastro.2012.10.001","article-title":"Elastography, Spleen Size, and Platelet Count Identify Portal Hypertension in Patients With Compensated Cirrhosis","volume":"144","author":"Berzigotti","year":"2013","journal-title":"Gastroenterology"},{"key":"ref_118","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.1111\/j.1365-2036.2008.03701.x","article-title":"Transient elastography accurately predicts presence of significant portal hypertension in patients with chronic liver disease","volume":"27","author":"Bureau","year":"2008","journal-title":"Aliment. Pharmacol. Ther."},{"key":"ref_119","doi-asserted-by":"crossref","first-page":"2173","DOI":"10.1002\/hep.28824","article-title":"Noninvasive tools and risk of clinically significant portal hypertension and varices in compensated cirrhosis: The \u201cAnticipate\u201d study","volume":"64","author":"Abraldes","year":"2016","journal-title":"Hepatology"},{"key":"ref_120","doi-asserted-by":"crossref","first-page":"723","DOI":"10.14309\/ajg.0000000000000994","article-title":"Noninvasive Diagnosis of Portal Hypertension in Patients With Compensated Advanced Chronic Liver Disease","volume":"116","author":"Pons","year":"2020","journal-title":"Am. J. Gastroenterol."},{"key":"ref_121","doi-asserted-by":"crossref","first-page":"3324","DOI":"10.1002\/hep4.2091","article-title":"Noninvasive predictors of clinically significant portal hypertension in NASH cirrhosis: Validation of ANTICIPATE models and development of a lab-based model","volume":"6","author":"Rabiee","year":"2022","journal-title":"Hepatol. Commun."},{"key":"ref_122","doi-asserted-by":"crossref","unstructured":"Jachs, M., Hartl, L., Simbrunner, B., Bauer, D., Paternostro, R., Scheiner, B., Balcar, L., Semmler, G., St\u00e4ttermayer, A.F., and Pinter, M. (2022). The Sequential Application of Baveno VII Criteria and VITRO Score Improves Diagnosis of Clinically Significant Portal Hypertension. Clin. Gastroenterol. Hepatol.","DOI":"10.1016\/j.cgh.2022.09.032"},{"key":"ref_123","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1016\/j.jhep.2021.05.025","article-title":"EASL Clinical Practice Guidelines on non-invasive tests for evaluation of liver disease severity and prognosis\u20142021 update","volume":"75","author":"Berzigotti","year":"2021","journal-title":"J. Hepatol."},{"key":"ref_124","doi-asserted-by":"crossref","first-page":"1825","DOI":"10.14309\/ajg.0000000000001887","article-title":"A Combined Baveno VII and Spleen Stiffness Algorithm to Improve the Noninvasive Diagnosis of Clinically Significant Portal Hypertension in Patients With Compensated Advanced Chronic Liver Disease","volume":"117","author":"Dajti","year":"2022","journal-title":"Am. J. Gastroenterol."},{"key":"ref_125","doi-asserted-by":"crossref","first-page":"2276","DOI":"10.1016\/j.cgh.2021.10.023","article-title":"Decompensation in Advanced Nonalcoholic Fatty Liver Disease May Occur at Lower Hepatic Venous Pressure Gradient Levels Than in Patients With Viral Disease","volume":"20","author":"Bassegoda","year":"2021","journal-title":"Clin. Gastroenterol. Hepatol."},{"key":"ref_126","doi-asserted-by":"crossref","unstructured":"European Association for the Study of the Liver (EASL), European Association for the Study of Diabetes (EASD), and European Association for the Study of Obesity (EASO) (2016). EASL-EASD-EASO Clinical Practice Guidelines for the management of non-alcoholic fatty liver disease. J. Hepatol., 64, 1388\u20131402.","DOI":"10.1016\/j.jhep.2015.11.004"},{"key":"ref_127","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1111\/apt.17346","article-title":"A practical use of noninvasive tests in clinical practice to identify high-risk patients with nonalcoholic steatohepatitis","volume":"57","author":"Younossi","year":"2023","journal-title":"Aliment. Pharmacol. Ther."},{"key":"ref_128","doi-asserted-by":"crossref","first-page":"1657","DOI":"10.1053\/j.gastro.2021.07.049","article-title":"Clinical Care Pathway for the Risk Stratification and Management of Patients With Nonalcoholic Fatty Liver Disease","volume":"161","author":"Kanwal","year":"2021","journal-title":"Gastroenterology"},{"key":"ref_129","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1111\/j.1464-5491.2006.01858.x","article-title":"Metabolic syndrome\u2014A new world-wide definition. A Consensus Statement from the International Diabetes Federation","volume":"23","author":"Alberti","year":"2006","journal-title":"Diabet. Med."},{"key":"ref_130","first-page":"1006","article-title":"Diagnostic accuracy of non-invasive tests for advanced fibrosis in patients with NAFLD: An individual patient data meta-analysis","volume":"71","author":"Lee","year":"2021","journal-title":"Gut"},{"key":"ref_131","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1002\/hep.21669","article-title":"FIB-4: An inexpensive and accurate marker of fibrosis in HCV infection. comparison with liver biopsy and fibrotest","volume":"46","author":"Mallet","year":"2007","journal-title":"Hepatology"},{"key":"ref_132","doi-asserted-by":"crossref","first-page":"1877","DOI":"10.1016\/j.cgh.2018.12.031","article-title":"Diagnostic Accuracy of Noninvasive Fibrosis Models to Detect Change in Fibrosis Stage","volume":"17","author":"Siddiqui","year":"2019","journal-title":"Clin. Gastroenterol. Hepatol."},{"key":"ref_133","doi-asserted-by":"crossref","first-page":"1265","DOI":"10.1136\/gut.2010.216077","article-title":"Simple non-invasive fibrosis scoring systems can reliably exclude advanced fibrosis in patients with non-alcoholic fatty liver disease","volume":"59","author":"McPherson","year":"2010","journal-title":"Gut"},{"key":"ref_134","doi-asserted-by":"crossref","first-page":"1104","DOI":"10.1016\/j.cgh.2009.05.033","article-title":"Comparison of Noninvasive Markers of Fibrosis in Patients With Nonalcoholic Fatty Liver Disease","volume":"7","author":"Shah","year":"2009","journal-title":"Clin. Gastroenterol. Hepatol."},{"key":"ref_135","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1038\/ajg.2016.453","article-title":"Age as a Confounding Factor for the Accurate Non-Invasive Diagnosis of Advanced NAFLD Fibrosis","volume":"112","author":"McPherson","year":"2017","journal-title":"Am. J. Gastroenterol."},{"key":"ref_136","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1002\/hep4.1841","article-title":"Fibrosis-4 Index as an Independent Predictor of Mortality and Liver-Related Outcomes in NAFLD","volume":"6","author":"Milligan","year":"2022","journal-title":"Hepatol. Commun."},{"key":"ref_137","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1111\/liv.15295","article-title":"FIB -4 and incident severe liver outcomes in patients with undiagnosed chronic liver disease: A Fine-Gray competing risk analysis","volume":"43","author":"Schreiner","year":"2022","journal-title":"Liver Int."},{"key":"ref_138","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1016\/j.jhep.2019.03.033","article-title":"Prospective evaluation of a primary care referral pathway for patients with non-alcoholic fatty liver disease","volume":"71","author":"Srivastava","year":"2019","journal-title":"J. Hepatol."},{"key":"ref_139","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.1016\/j.jhep.2020.11.050","article-title":"Refining the Baveno VI elastography criteria for the definition of compensated advanced chronic liver disease","volume":"74","author":"Papatheodoridi","year":"2020","journal-title":"J. Hepatol."},{"key":"ref_140","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1016\/j.jhep.2021.12.031","article-title":"Non-invasive tests accurately stratify patients with NAFLD based on their risk of liver-related events","volume":"76","author":"Boursier","year":"2022","journal-title":"J. Hepatol."},{"key":"ref_141","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1002\/hep4.1208","article-title":"A Pragmatic Approach Identifies a High Rate of Nonalcoholic Fatty Liver Disease With Advanced Fibrosis in Diabetes Clinics and At-Risk Populations in Primary Care","volume":"2","author":"Patel","year":"2018","journal-title":"Hepatol. Commun."},{"key":"ref_142","doi-asserted-by":"crossref","first-page":"e000904","DOI":"10.1136\/bmjdrc-2019-000904","article-title":"Screening for non-alcoholic fatty liver disease in type 2 diabetes using non-invasive scores and association with diabetic complications","volume":"8","author":"Ciardullo","year":"2020","journal-title":"BMJ Open Diabetes Res. Care"},{"key":"ref_143","doi-asserted-by":"crossref","unstructured":"Boursier, J., Canivet, C.M., Costentin, C., Lannes, A., Delamarre, A., Sturm, N., Le Bail, B., Michalak, S., Oberti, F., and Hilleret, M.-N. (2022). Impact of Type 2 Diabetes on the Accuracy of Noninvasive Tests of Liver Fibrosis With Resulting Clinical Implications. Clin. Gastroenterol. Hepatol.","DOI":"10.1016\/j.cgh.2022.02.059"},{"key":"ref_144","doi-asserted-by":"crossref","unstructured":"Rinella, M.E., Neuschwander-Tetri, B.A., Siddiqui, M.S., Abdelmalek, M.F., Caldwell, S., Barb, D., Kleiner, D.E., and Loomba, R. (2023). AASLD practice guidance on the clinical assessment and management of nonalcoholic fatty liver disease. Hepatology.","DOI":"10.1097\/HEP.0000000000000323"},{"key":"ref_145","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1136\/gutjnl-2022-327777","article-title":"Liver stiffness thresholds to predict disease progression and clinical outcomes in bridging fibrosis and cirrhosis","volume":"72","author":"Loomba","year":"2023","journal-title":"Gut"},{"key":"ref_146","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1111\/apt.16575","article-title":"Review article: Non-alcoholic fatty liver disease and cardiovascular diseases: Associations and treatment considerations","volume":"54","author":"Polyzos","year":"2021","journal-title":"Aliment. Pharmacol. Ther."},{"key":"ref_147","doi-asserted-by":"crossref","unstructured":"Ballestri, S., Mantovani, A., Baldelli, E., Lugari, S., Maurantonio, M., Nascimbeni, F., Marrazzo, A., Romagnoli, D., Tar-gher, G., and Lonardo, A. (2021). Liver fibrosis biomarkers accurately exclude advanced fibrosis and are associated with higher car-diovascular risk scores in patients with NAFLD or viral chronic liver disease. Diagnostics, 11.","DOI":"10.3390\/diagnostics11010098"},{"key":"ref_148","doi-asserted-by":"crossref","first-page":"1","DOI":"10.20517\/mtod.2022.23","article-title":"Liver fibrosis in nonalcoholic fatty liver disease patients: Noninvasive evaluation and correlation with cardiovascular disease and mortality","volume":"3","author":"Ballestri","year":"2023","journal-title":"Metab. Target Organ Damage"},{"key":"ref_149","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1038\/s41575-021-00502-9","article-title":"Metabolomics and lipidomics in NAFLD: Biomarkers and non-invasive diagnostic tests","volume":"18","author":"Masoodi","year":"2021","journal-title":"Nat. Rev. Gastro-Enterol. Hepatol."},{"key":"ref_150","doi-asserted-by":"crossref","first-page":"1263","DOI":"10.1002\/hep4.1556","article-title":"Characterization and Proteome of Circulating Extracellular Vesicles as Potential Biomarkers for NASH","volume":"4","author":"Povero","year":"2020","journal-title":"Hepatol. Commun."}],"container-title":["Diagnostics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2075-4418\/13\/4\/788\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T18:36:42Z","timestamp":1760121402000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2075-4418\/13\/4\/788"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,2,19]]},"references-count":150,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2023,2]]}},"alternative-id":["diagnostics13040788"],"URL":"https:\/\/doi.org\/10.3390\/diagnostics13040788","relation":{},"ISSN":["2075-4418"],"issn-type":[{"value":"2075-4418","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,2,19]]}}}